This is a lung condition that happens when your body has an allergic reaction to a type of fungus called Aspergillus. It usually affects people who already have asthma. The fungus causes inflammation in the airways, leading to symptoms like wheezing and coughing. It's important to see a doctor if you suspect this condition.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Allergic Bronchopulmonary Aspergillosis (ABPA)?
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic lung condition caused by the immune system overreacting to Aspergillus, a common mold. Most people breathe in Aspergillus spores every day without any effect. In ABPA, the fungus settles and grows in the airways, and the body mounts a strong allergic response to it rather than simply clearing it. It is not an invasive fungal infection: the fungus does not spread into lung tissue, and the harm comes from the inflammation the reaction causes. ABPA develops mostly in people who already have asthma or cystic fibrosis, and less often in people with bronchiectasis or chronic obstructive pulmonary disease (COPD). It often looks like asthma that is getting harder to control: more coughing, wheezing and shortness of breath, frequent flare-ups, and sometimes coughing up thick plugs of mucus. It matters because the ongoing inflammation and mucus plugging can permanently widen and scar the airways, a condition called bronchiectasis. Finding and treating ABPA early helps prevent that damage.
The underlying cause is an exaggerated allergic (type 2) immune response to Aspergillus that has taken hold in the airways. Why only some people react this way is not fully understood. Airways that already clear mucus poorly or are already inflamed, as in asthma and cystic fibrosis, appear to give the fungus a place to grow and the immune system a reason to overreact. Allergy to Aspergillus is common among people with asthma, and a minority of those who are sensitized go on to develop ABPA. It is not limited to severe asthma: some people with mild asthma develop it too, which is one reason it can be missed. A similar illness, called allergic bronchopulmonary mycosis, can be caused by other molds. Aspergillus lives in soil, compost, decaying plants and damp indoor spaces. Breathing in large numbers of spores, for example while gardening or in a moldy building, may set off flare-ups in someone who already has ABPA.
There is no single test for ABPA. A lung specialist puts together blood tests and imaging in someone with asthma, cystic fibrosis or another chronic lung disease, or whose symptoms and scans suggest it. The starting point is a blood test for IgE antibodies directed specifically at Aspergillus, which shows the immune system is sensitized to the fungus. IgE (immunoglobulin E) is the antibody involved in allergic reactions. The next key test is total IgE, the overall amount of this antibody in the blood. Under current international criteria, a total IgE of 500 IU/mL (international units per milliliter) or higher supports ABPA, and many people with ABPA have levels far above that. The diagnosis also needs at least two of the following: IgG antibodies against Aspergillus (a sign of longer-term immune exposure), a blood eosinophil count of 500 cells per microliter or more (eosinophils are white blood cells that drive allergic inflammation), or chest imaging typical of ABPA. A thin-slice chest CT (computed tomography) scan is recommended at the start. It can show widened airways (bronchiectasis), airways blocked by mucus plugs, and, in some people, mucus that looks unusually dense on the scan, a finding that strongly points to ABPA. The CT also helps judge how much damage is present and the risk of future flare-ups. Breathing tests (spirometry) measure how well air moves in and out of the lungs. Total IgE then becomes a tracking measure: it falls with treatment, and a rise of 50% or more from a person's stable level can signal a flare.
Treatment aims to calm the allergic reaction, reduce the fungus in the airways, ease symptoms, prevent flare-ups and stop bronchiectasis from progressing. ABPA usually responds well to treatment. For a new diagnosis or a flare with symptoms, there are two main first options. Oral steroid pills such as prednisolone work fastest; a typical course starts at a moderate dose and tapers off over about four months. Itraconazole, an antifungal pill, reduces the fungus driving the reaction. It works about as well as steroids but more slowly, with fewer side effects, and is the usual choice when steroids are unsuitable. Combining the two from the start is not routinely recommended, though it may help people who keep relapsing. High-dose inhaled steroids alone do not control ABPA, although they remain part of asthma care. Each option has trade-offs that shape monitoring. Steroid courses can raise blood sugar, blood pressure and weight, and affect mood and sleep, so these are checked during treatment. Itraconazole interacts with many medicines, including the inhaled steroids budesonide and fluticasone, where the combination can cause steroid side effects (Cushing's syndrome); it also requires liver tests and often blood tests to confirm the drug is absorbed well enough to work. A full medication list matters before starting it. Some people relapse each time treatment stops. Options for them include long-term itraconazole, inhaled (nebulized) amphotericin B, another antifungal, or a biologic injection. Biologics are antibody medicines that block parts of the allergic response. Omalizumab (Xolair), which targets IgE, has the most experience behind it, and others used for severe asthma have also been tried. In ABPA they are used off-label, and the evidence comes from small studies. Long-term daily steroids are a last resort. Pregnancy changes the choices: antifungal pills and biologics are generally avoided, and steroids are used instead. Children and people with cystic fibrosis are treated on the same principles with extra precautions, such as attention to growth in children and to steroid-related diabetes in cystic fibrosis. Alongside any ABPA treatment, the underlying asthma or bronchiectasis needs its own ongoing care, such as inhalers and airway clearance.
Most people improve within a few months of starting treatment. The first check of how well it is working usually comes after 8 to 12 weeks and combines symptoms, a chest X-ray and total IgE. A good response means breathing feels clearly better, scan changes clear, and IgE drops by at least a fifth. ABPA is often long-term even when it responds well. Flares can return months or years later, especially in people with more extensive bronchiectasis or mucus plugging, and a smaller group (roughly 10 to 25%) need ongoing treatment to stay well. Others reach remission, meaning six months or more of stability off steroids. Follow-up typically includes a visit, IgE level and breathing tests every 3 to 6 months in the first year, then every 6 to 12 months. Day to day, life with ABPA largely means keeping asthma or cystic fibrosis well controlled and limiting heavy mold exposure. Activities that stir up a lot of spores, such as handling compost, mulch or rotting leaves, are worth reducing; when they can't be avoided, a well-fitted N95 mask helps. At home, fixing leaks and damp spots, ventilating bathrooms and kitchens, and maintaining heating and air-conditioning systems reduce indoor mold. When ABPA is caught early and kept under control, many people avoid significant lasting lung damage. If years of uncontrolled inflammation have already caused widespread bronchiectasis, frequent chest infections and gradually reduced lung function can follow, and a few people eventually need oxygen or specialist care for advanced lung disease.
If you have asthma or cystic fibrosis that is becoming harder to control despite your usual treatment, with more flare-ups, more steroid courses or coughing up thick plugs of mucus, ask whether you should be tested for ABPA. If you already have ABPA, contact your care team when breathing symptoms worsen and stay worse for more than a week or two, or you start coughing up mucus plugs again, since these can signal a flare that may need treatment and an IgE check. Also call if you develop side effects from treatment, such as very high blood sugar readings, mood changes, yellowing skin or eyes, or swelling of the legs, or before starting any new medicine while taking itraconazole. Call your care team right away if you cough up blood.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Allergic Bronchopulmonary Aspergillosis (ABPA) is like, what's helped you, or ask the community a question.